À propos de Xingxu Kangda

Spécialiste des seringues de sécurité rétractables

Shaanxi Xingxukangda Medical Technology développe et fabrique des seringues de sécurité rétractables stériles et des solutions automatisées associées.

杏旭康达 XINGXU KANGDA

Profil de l'entreprise

Une maîtrise industrielle derrière chaque produit

Xingxu Medical Devices (Suzhou) a été créée en 2016. Une unité de production a été implantée à Lintong, Shaanxi en 2023 pour le développement et la fabrication de seringues de sécurité.

L'activité intègre R&D, moules de précision, assemblage automatisé, conception de procédés propres et fourniture B2B internationale.

2016Activité de Suzhou créée
2023Site de Shaanxi créé
2026Coopération B2B mondiale

Integrated company scope

Product, tooling and automation developed around one safety platform

Xingxu Kangda brings several connected capabilities together around retractable safety syringe development and manufacturing.

01

Product development

Product structures are developed around controlled manual needle retraction and single-use disablement.

02

Precision tooling

Mold development supports the geometry and repeatability required by syringe components.

03

Automation engineering

Assembly equipment and process design connect product development with scalable manufacturing.

04

International B2B support

Product information, videos and available documents support distributor and institutional evaluation.

Working principles

A professional basis for long-term B2B communication

The company profile is strengthened by showing how technical and commercial discussions are approached.

01

Be specific

Product conversations begin with structure, capacity, needle specification and intended market.

02

Show the evidence

Available product videos, certificates and patent documents are presented for direct review.

03

Keep communication direct

Buyers can reach the product team through the inquiry form, email or WhatsApp.

Public records in China

Company development reflected in public sources

The following milestones link to Chinese corporate, media and regulatory records. Planned capacity and project figures are presented as reported at the time, not as current supply commitments.

WA